These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 25671300)
1. Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms. Kaemmerer D; Reimann C; Specht E; Wirtz RM; Sayeg M; Baum RP; Schulz S; Lupp A Oncotarget; 2015 Feb; 6(5):3346-58. PubMed ID: 25671300 [TBL] [Abstract][Full Text] [Related]
2. Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance. Li XX; Li RJ; Zhao LJ; Liu NB; Wang P Int J Clin Exp Pathol; 2015; 8(11):14676-84. PubMed ID: 26823791 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects. Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241 [TBL] [Abstract][Full Text] [Related]
4. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival. Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer. Stumpf C; Kaemmerer D; Neubauer E; Sänger J; Schulz S; Lupp A J Cancer Res Clin Oncol; 2018 Oct; 144(10):1921-1932. PubMed ID: 30076481 [TBL] [Abstract][Full Text] [Related]
6. Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis. Walter RF; Werner R; Ting S; Vollbrecht C; Theegarten D; Christoph DC; Schmid KW; Wohlschlaeger J; Mairinger FD Oncotarget; 2015 Sep; 6(28):24690-8. PubMed ID: 26008974 [TBL] [Abstract][Full Text] [Related]
7. Expression of delta-like protein 3 is reproducibly present in a subset of small cell lung carcinomas and pulmonary carcinoid tumors. Xie H; Boland JM; Maleszewski JJ; Aubry MC; Yi ES; Jenkins SM; Koepplin JW; Terra SBSP; Mansfield AS; Roden AC Lung Cancer; 2019 Sep; 135():73-79. PubMed ID: 31447005 [TBL] [Abstract][Full Text] [Related]
8. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Alcala N; Leblay N; Gabriel AAG; Mangiante L; Hervas D; Giffon T; Sertier AS; Ferrari A; Derks J; Ghantous A; Delhomme TM; Chabrier A; Cuenin C; Abedi-Ardekani B; Boland A; Olaso R; Meyer V; Altmuller J; Le Calvez-Kelm F; Durand G; Voegele C; Boyault S; Moonen L; Lemaitre N; Lorimier P; Toffart AC; Soltermann A; Clement JH; Saenger J; Field JK; Brevet M; Blanc-Fournier C; Galateau-Salle F; Le Stang N; Russell PA; Wright G; Sozzi G; Pastorino U; Lacomme S; Vignaud JM; Hofman V; Hofman P; Brustugun OT; Lund-Iversen M; Thomas de Montpreville V; Muscarella LA; Graziano P; Popper H; Stojsic J; Deleuze JF; Herceg Z; Viari A; Nuernberg P; Pelosi G; Dingemans AMC; Milione M; Roz L; Brcic L; Volante M; Papotti MG; Caux C; Sandoval J; Hernandez-Vargas H; Brambilla E; Speel EJM; Girard N; Lantuejoul S; McKay JD; Foll M; Fernandez-Cuesta L Nat Commun; 2019 Aug; 10(1):3407. PubMed ID: 31431620 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers. Kaemmerer D; Specht E; Sänger J; Wirtz RM; Sayeg M; Schulz S; Lupp A J Clin Endocrinol Metab; 2015 Mar; 100(3):831-40. PubMed ID: 25494861 [TBL] [Abstract][Full Text] [Related]
10. Molecular markers help characterize neuroendocrine lung tumors. Rusch VW; Klimstra DS; Venkatraman ES Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer. Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754 [TBL] [Abstract][Full Text] [Related]
12. CD44 and OTP are strong prognostic markers for pulmonary carcinoids. Swarts DR; Henfling ME; Van Neste L; van Suylen RJ; Dingemans AM; Dinjens WN; Haesevoets A; Rudelius M; Thunnissen E; Volante M; Van Criekinge W; van Engeland M; Ramaekers FC; Speel EJ Clin Cancer Res; 2013 Apr; 19(8):2197-207. PubMed ID: 23444222 [TBL] [Abstract][Full Text] [Related]
13. Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer. Fujii K; Miyata Y; Takahashi I; Koizumi H; Saji H; Hoshikawa M; Takagi M; Nishimura T; Nakamura H Proteomics Clin Appl; 2018 Nov; 12(6):e1800015. PubMed ID: 29888431 [TBL] [Abstract][Full Text] [Related]
14. Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer. Zhou R; Zhou X; Yin Z; Guo J; Hu T; Jiang S; Liu L; Dong X; Zhang S; Wu G Oncotarget; 2015 Dec; 6(42):44609-22. PubMed ID: 26587830 [TBL] [Abstract][Full Text] [Related]
15. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy. Kaemmerer D; Träger T; Hoffmeister M; Sipos B; Hommann M; Sänger J; Schulz S; Lupp A Oncotarget; 2015 Sep; 6(29):27566-79. PubMed ID: 26259237 [TBL] [Abstract][Full Text] [Related]
16. Co-expression of uPAR and CXCR4 promotes tumor growth and metastasis in small cell lung cancer. Li Y; Shen Y; Miao Y; Luan Y; Sun B; Qiu X Int J Clin Exp Pathol; 2014; 7(7):3771-80. PubMed ID: 25120753 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers. Iida Y; Masuda S; Nakanishi Y; Shimizu T; Nishimaki H; Takahashi M; Hikichi M; Maruoka S; Gon Y; Takahashi N; Hashimoto S Hum Pathol; 2018 Sep; 79():127-134. PubMed ID: 29787820 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of drs tumor suppressor gene in highly malignant human pulmonary neuroendocrine tumors. Shimakage M; Kodama K; Kawahara K; Kim CJ; Ikeda Y; Yutsudo M; Inoue H Oncol Rep; 2009 Jun; 21(6):1367-72. PubMed ID: 19424611 [TBL] [Abstract][Full Text] [Related]
19. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis. Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413 [TBL] [Abstract][Full Text] [Related]
20. Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2/Bax and prognostic factors for overall survival in patients with lung carcinoid. Velinovic M; Jankovic R; Jovanovic D; Skodric Trifunovic V; Gavrilovic D; Stojsic J; Cavic M J BUON; 2019; 24(1):256-266. PubMed ID: 30941978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]